Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- Over the last 9 months, nurses have been protesting a federal regulation that they say would drive up student loan debt, exacerbate workforce shortages, and threaten patient access to care. Last week, they put their words into...
Read full article →(MedPage Today) -- A sweeping proposed rule that would transfer federal grantmaking decisions from scientific experts to senior political appointees is "dystopian," "disastrous," and a "flagrant assault on our democracy," scientists and health...
Read full article →(MedPage Today) -- For many patients, taking a controlled medication feels like any ordinary medical decision. You're prescribed something for sleep, anxiety, ADHD, or pain. You're counseled on risks and side effects. You pick it up from the pharmacy...
Read full article →(MedPage Today) -- CHICAGO -- Sacituzumab govitecan (SG, Trodelvy) added to pembrolizumab (Keytruda) extended a surrogate measure of long-term clinical outcomes compared with chemotherapy plus pembrolizumab in patients with PD-L1-positive metastatic...
Read full article →Mayo Clinic plans to develop and deploy a frontier AI model specifically designed for healthcare in collaboration with Microsoft.
Read full article →A new federal report suggests that Medicare Advantage plans may have earned millions in overpayments tied to unsupported stroke diagnoses.
Read full article →Forty-six percent of respondents in the 2025 Consumer Adoption of Digital Health Survey reported owning a wearable specifically, and 57% of respondents reported owning at least one wearable or other connected device.
Read full article →Employed at a National Institutes of Health lab in Montana, the two allegedly brought deactivated virus from the Republic of the Congo without a permit.
Read full article →Fulcrum Therapeutics drug pociredir posted early clinical trial results showing signs of treating sickle cell disease with no reports of serious complications. But the biotech is discontinuing this program due to FDA concerns that drugs in this class of medicines raise the risk of cancer. The post FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug appeared first on MedCity News .
Read full article →Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.
Read full article →Wellness influencers are promoting supplements of cow colostrum, the first milk that mammals produce after giving birth, for advancing immunity and a healthy gut. Does science back up their advice?
Read full article →(MedPage Today) -- The Trump administration moved quickly to dismantle the U.S. Agency for International Development (USAID) after taking office in early 2025, implementing a funding freeze, issuing stop-work orders, and carrying out mass layoffs...
Read full article →